Exploring Assayquant Continuous Kinase Assay Discovery On Target Presentation
Exploring Assayquant Continuous Kinase Assay Discovery On Target Presentation reveals several interesting facts.
- Unlock the future of drug discovery at the 23rd Annual
- This webinar will discuss the need for both targeted activity, as well as appropriate selectivity, as key requisites in the
- What to expect at the 23rd Annual
- In this video, our Sr. VP of
- Uncover the power and kinetic insights of a
In-Depth Information on Assayquant Continuous Kinase Assay Discovery On Target Presentation
PhosphoSens Watch as our President, CEO & CSO, Erik Schaefer, Ph.D., goes into detail about the science behind our PhosphoSens ... Discover the advanced capabilities of Promega's NanoBRET™ Look at your therapeutic strategy through the lens of energy metabolism. Identify new therapeutic
Identifying bona fide hits efficiently and effectively is a challenge in any small molecule drug
Stay tuned for more updates related to Assayquant Continuous Kinase Assay Discovery On Target Presentation.
